PDCD1 and neoplasm: Immune cells such as T cells can express PD-1, and when PD-1 binds to PD-L1 ligands expressed by cytokine-stimulated tumor cells, it can aggregate with T-cell receptor (TCR) and induce the dephosphorylation of the proximal TCR signaling molecules, thereby inhibiting T-cell activation.